Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Women's Health Therapeutics Market Poised for Growth: Innovation, Investment and Global Impact

This image opens in the lightbox

News provided by

BCC Research LLC

08 May, 2025, 18:17 GMT

Share this article

Share toX

Share this article

Share toX

"BCC Research presents an in-depth analysis of how innovations, market dynamics, regional trends and ESG strategies are shaping the $81.2 billion women's health therapeutics market."

BOSTON, May 8, 2025 /PRNewswire/ -- As global awareness of gender-specific medicine continues to rise, the women's health therapeutics market is entering a pivotal era of innovation and investment. Leading pharmaceutical players—such as Pfizer Inc., Eli Lilly and Company, and F. Hoffmann-La Roche Ltd.—are accelerating the development of targeted therapies to address conditions like breast cancer, menopause, PCOS and endometriosis.

According to the report, growing emphasis on personalized medicine and biologics is reshaping corporate strategies, especially as North America leads global expansion and emerging technologies unlock new care models. While the market is projected to grow at a CAGR of 5.7% from 2024 to 2029, stakeholders must navigate regulatory hurdles and rising treatment costs to capture long-term value. This shift marks a profound transformation in how biotech investors, manufacturers, and healthcare providers approach women's health—transitioning it from underserved to a global priority.

Market Overview: Key Insights and Forecast
BCC Research's latest report on Women's Health Therapeutics: Technologies and Global Markets provides a comprehensive breakdown of market trends, investment dynamics, and therapeutic pipelines. The global market is expected to grow from $61.5 billion in 2024 to $81.2 billion by 2029, reflecting a shift toward biologics, hormonal therapies, and digital health solutions.

The report offers strategic insights across key areas, including segmentation analysis, competitive intelligence, regulatory structures, ESG perspectives and emerging technologies that are reshaping the global women's health therapeutics industry.

Market Leadership in Transition

The women's health therapeutics market is undergoing significant transformation, driven by an aging female population and rising demand for condition-specific treatment options. Companies like Pfizer, Eli Lilly and Novartis AG are actively investing in late-stage R&D for areas such as menopause and postmenopausal osteoporosis (Chapter 5, Pipeline Assessment and Analysis; Chapter 8, Competitive Landscape).

The breast cancer segment remains the most dominant, supported by increasing incidence rates and continued innovation in monoclonal antibodies and biosimilars (Chapter 7, Market Segmentation Analysis).

Emerging Technologies and Investment Trends

As outlined in Chapter 4 (Emerging Technologies), cutting-edge innovations such as gene therapy, CRISPR, and transdermal delivery platforms are opening doors for safer, more personalized treatments. These technologies are also enabling commercialization models in digital health and remote care—areas expected to see strong growth.

North America leads regional expansion, projected to grow from $28.4 billion in 2024 to $37.4 billion by 2029 at a 5.6% CAGR (Chapter 7, Regional Analysis). This growth is fueled by robust R&D infrastructure, regulatory support and access to biologics and HRT. Meanwhile, Europe and the Asia-Pacific region present significant opportunities as healthcare systems modernize and policies evolve.

Pipeline Assessment and Analysis

Chapter 5 details how companies are diversifying pipelines across hormonal, non-hormonal and biologic therapies aimed at improving efficacy and minimizing side effects.

Roche, in particular, has solidified its leadership in the U.S. market through its strong presence in the breast cancer, postmenopausal osteoporosis, menopause, endometriosis, and PCOS segments. (Chapter 8, Competitive Landscape)

Regulatory and Access Challenges

Chapter 3 (Market Dynamics) highlights persistent barriers such as high treatment costs and slow regulatory pathways, particularly in low-income regions where access to diagnostics and therapies remains limited.

Chapter 6 (Regulatory Structure) explains how regional discrepancies in clinical trial approvals and intellectual property rules impact time-to-market and ROI projections for drug developers.

Strategic Outlook: The Road Ahead

According to Chapter 9 (ESG Perspective), the industry is increasingly aligning with environmental, social and governance (ESG) goals—focusing on inclusivity in clinical trials, sustainable manufacturing, and broader access to care. Firms integrating ESG into product pipelines and geographic strategies are well-positioned to win both market share and investor confidence.

With rising awareness, policy support and a wave of therapeutic innovation, women's health is becoming central to the future of equitable, personalized healthcare. The next five years will be critical for companies to lead, adapt and innovate in this fast-evolving space.

Report Synopsis 

Report Metric

Details

Base year considered

2023

Forecast period considered

2024-2029

Base year market size

$58.3 billion

Market size forecast

$81.2 billion

Growth rate

CAGR of 5.7% for the forecast period of 2024-2029

Segments covered

Women's Health Disorders, and Region

Regions covered

North America, Europe, Asia-Pacific, and the Rest of the World (RoW)

Countries covered

U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China

Market drivers

•         Rising geriatric population of women.

•         Rising awareness of and accessibility to healthcare and advanced therapeutic products.

•         Advances in personalized medicine.

•         Emerging markets.

Additional Insights:

  •  The women's health therapeutics market is expanding rapidly, driven by increasing awareness, technological advancements, and increased attention to under-addressed conditions such as menopause, endometriosis, and polycystic ovary syndrome (PCOS).
  •  Governments and healthcare organizations around the world are implementing initiatives to enhance access to women's health treatments, including funding programs for maternal care, reproductive health, and breast cancer screening.

Market leaders include:

  •  AbbVie Inc.
  •  Amgen Inc.
  • Asahi Kasei Corp.
  •  AstraZeneca
  •  Bayer AG
  •  Bristol-Myers Squibb Co.
  •  Eisai Co. Ltd.
  •  F. Hoffmann-La Roche Ltd.
  •  Johnson & Johnson Services Inc.
  •  Lilly
  •  Merck & Co. Inc.
  •  Novartis AG
  •  Novo Nordisk A/S
  •  Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

Navigate Uncertainty with Confidence

In times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we're here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape—providing you with the clarity you need to make informed decisions. We believe that timely, expert market intelligence should be accessible to all. That's why, for a limited time, we're offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights.

Get your copy of the report directly from BCC Research.

To request more information or complete your purchase, connect with us at info@bccresearch.com.

About BCC Research

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

Contact Us

Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA

Email: info@bccresearch.com

Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo - https://mma.prnewswire.com/media/2183242/5309119/BCC_Research_Logo.jpg

Modal title

Also from this source

Global Medical Imaging Market Projected to Reach $82.6 Billion by 2029, According to BCC Research

Global Medical Imaging Market Projected to Reach $82.6 Billion by 2029, According to BCC Research

According to the latest study from BCC Research, "Medical Imaging: A BCC Research Outlook," the market is expected to grow from $63.4 billion in 2024 ...

In Vitro Diagnostics: Technologies Transforming Global Healthcare Markets

In Vitro Diagnostics: Technologies Transforming Global Healthcare Markets

According to the latest study from BCC Research, In Vitro Diagnostics: Technologies and Global Markets is projected to grow from $94.7 billion in...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Publishing & Information Services

Publishing & Information Services

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.